Literature DB >> 16596706

Proteomic characterization of inter-alpha inhibitor proteins from human plasma.

Djuro Josic1, Mari Kino Brown, Feilei Huang, Yow-Pin Lim, Marijana Rucevic, James G Clifton, Douglas C Hixson.   

Abstract

Inter-alpha inhibitor proteins (IaIp) are a family of structurally related serine protease inhibitors found in relatively high concentrations in human plasma. Recent studies have implicated a role for IaIp in sepsis, and have demonstrated their potential as biomarkers in sepsis and cancer. For characterization of isolated IaI proteins and contaminating proteins during the last steps of the purification process, SELDI-TOF MS and HPLC-ESI-MS/MS were used. After separation by SDS-PAGE or 2-DE, polypeptide bands of 80, 125 and 250 kDa were excised from gels and digested by trypsin. The tryptic peptides were analyzed by both MS methods. The main contamination during the purification process, a band of 80 kDa, contains mainly IaIp heavy chain (HC) H3. HC H1 and H2 were also found in this band. In addition, some vitamin K-dependent clotting factors and inhibitors and other plasma proteins were identified. The 125-kDa band, representing the pre-alpha inhibitor, was found to contain both bikunin and HC H3. The presence of other HC H1, H2 and the recently described HC H4 was also detected by SELDI-TOF MS. The presence of HC H1, H2, and H3 in the 125-kDa band was confirmed by ESI-MS/MS, but not the presence of the H4. Three polypeptides, H1 and H2 together with bikunin, were identified in the 250-kDa band, representing the ITI, by both MS techniques. Once again, the presence of H4 was detected in this band only by SELDI-TOF MS, but the number of corresponding peptides was still not sufficient for final identification of this polypeptide. The importance of the application of proteomic methods for the proper evaluation of therapeutic drugs based on human plasma is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16596706     DOI: 10.1002/pmic.200500563

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  23 in total

Review 1.  The role of proteomics in plasma fractionation and quality control of plasma-derived therapeutic proteins.

Authors:  Dajana Gaso-Sokac; Djuro Josic
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

2.  Selectivity of monolithic supports under overloading conditions and their use for separation of human plasma and isolation of low abundance proteins.

Authors:  Marija Brgles; James Clifton; Robert Walsh; Feilei Huang; Marijana Rucevic; Lulu Cao; Douglas Hixson; Egbert Müller; Dj Josic
Journal:  J Chromatogr A       Date:  2010-12-03       Impact factor: 4.759

3.  Inter-alpha inhibitor proteins attenuate lipopolysaccharide-induced blood-brain barrier disruption and downregulate circulating interleukin 6 in mice.

Authors:  Aric F Logsdon; Michelle A Erickson; Xiaodi Chen; Joseph Qiu; Yow-Pin Lim; Barbara S Stonestreet; William A Banks
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-24       Impact factor: 6.200

4.  Inter-α inhibitor protein and its associated glycosaminoglycans protect against histone-induced injury.

Authors:  Hala Chaaban; Ravi S Keshari; Robert Silasi-Mansat; Narcis I Popescu; Padmaja Mehta-D'Souza; Yow-Pin Lim; Florea Lupu
Journal:  Blood       Date:  2015-01-28       Impact factor: 22.113

5.  Inter-α inhibitor proteins: a novel therapeutic strategy for experimental anthrax infection.

Authors:  Steven M Opal; Yow-Pin Lim; Patricia Cristofaro; Andrew W Artenstein; Noubar Kessimian; David Delsesto; Nicolas Parejo; John E Palardy; Edward Siryaporn
Journal:  Shock       Date:  2011-01       Impact factor: 3.454

6.  Inter-α inhibitor proteins maintain neutrophils in a resting state by regulating shape and reducing ROS production.

Authors:  Soe Soe Htwe; Hidenori Wake; Keyue Liu; Kiyoshi Teshigawara; Barbara S Stonestreet; Yow-Pin Lim; Masahiro Nishibori
Journal:  Blood Adv       Date:  2018-08-14

7.  Proteomic analysis for process development and control of therapeutic protein separation from human plasma.

Authors:  Xinli Yang; James Clifton; Feilei Huang; Spomenka Kovac; Douglas C Hixson; Djuro Josic
Journal:  Electrophoresis       Date:  2009-04       Impact factor: 3.535

8.  Plasma levels of inter-alpha inhibitor proteins in children with acute Dengue virus infection.

Authors:  Penelope Koraka; Yow-Pin Lim; Michael D Shin; Tatty E Setiati; Albert T A Mairuhu; Eric C M van Gorp; Augustinus Soemantri; Albert D M E Osterhaus; Byron E E Martina
Journal:  PLoS One       Date:  2010-04-06       Impact factor: 3.240

9.  Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription.

Authors:  Jason M Aliotta; Mandy Pereira; Kevin W Johnson; Nicole de Paz; Mark S Dooner; Napoleon Puente; Carol Ayala; Kate Brilliant; David Berz; David Lee; Bharat Ramratnam; Paul N McMillan; Douglas C Hixson; Djuro Josic; Peter J Quesenberry
Journal:  Exp Hematol       Date:  2010-01-15       Impact factor: 3.084

10.  Proteomic characterization of plasma-derived clotting factor VIII-von Willebrand factor concentrates.

Authors:  James G Clifton; Feilei Huang; Spomenka Kovac; Xinli Yang; Douglas C Hixson; Djuro Josic
Journal:  Electrophoresis       Date:  2009-10       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.